|
Eli Lilly and Co
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$1038
|
$962B |
15.1x |
33.3x |
|
Johnson & Johnson
|
United States of America |
Biopharmaceuticals,
Medical Devices,
Drug Development & Therapeutics
|
$219
|
$554B |
5.9x |
15.5x |
|
AbbVie
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Health & Beauty
|
$214
|
$442B |
7.3x |
16.9x |
|
Merck & Co
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$109
|
$293B |
4.5x |
9.8x |
|
Amgen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$330
|
$223B |
6.1x |
12.6x |
|
Pfizer
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$26
|
$192B |
3.1x |
7.7x |
|
Gilead Sciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$125
|
$173B |
5.9x |
10.8x |
|
Bristol-Myers Squibb
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$55
|
$147B |
3.1x |
7.9x |
|
Vertex Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Regenerative Medicine
|
$441
|
$108B |
9.0x |
19.9x |
|
Regeneron Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$733
|
$71.3B |
5.0x |
14.2x |
|
Zoetis
|
United States of America |
Pet Care,
Biopharmaceuticals,
Drug Development & Therapeutics
|
$125
|
$60.1B |
6.4x |
14.6x |
|
Alnylam Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$359
|
$46.0B |
12.3x |
65.7x |
|
Insmed
|
United States of America |
Drug Development & Therapeutics
|
$161
|
$33.3B |
64.8x |
-29.8x |
|
Viatris
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$13
|
$28.4B |
2.0x |
6.9x |
|
Biogen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$164
|
$26.8B |
2.7x |
8.8x |
|
Revolution Medicines
|
United States of America |
Drug Development & Therapeutics
|
$120
|
$21.5B |
5587.1x |
-19.0x |
|
Incyte
|
United States of America |
Drug Development & Therapeutics
|
$106
|
$18.0B |
3.6x |
11.3x |
|
United Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$465
|
$16.9B |
5.3x |
10.1x |
|
BridgeBio Pharma
|
United States of America |
Drug Development & Therapeutics
|
$76
|
$15.9B |
32.2x |
-34.7x |
|
Elanco
|
United States of America |
Drug Development & Therapeutics
|
$25
|
$15.7B |
3.4x |
17.7x |
|
Jazz Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$169
|
$13.7B |
3.2x |
14.5x |
|
Regencell Bioscience
|
United States of America |
Drug Development & Therapeutics
|
$27
|
$13.6B |
N/A |
N/A |
|
Moderna
|
United States of America |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
$42
|
$12.6B |
6.6x |
-3.9x |
|
Neurocrine Biosciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$132
|
$12.5B |
4.4x |
19.0x |
|
Summit Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$17
|
$12.5B |
N/A |
-12.1x |
|
Roivant Sciences
|
United States of America |
Drug Development & Therapeutics,
Drug Delivery Systems
|
$23
|
$11.8B |
643.0x |
-10.5x |
|
Ionis Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$76
|
$11.6B |
13.0x |
-31.4x |
|
Exelixis
|
United States of America |
Drug Development & Therapeutics
|
$44
|
$11.0B |
4.7x |
11.7x |
|
BioNTech
|
United States of America |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
$109
|
$10.8B |
3.5x |
-8.7x |
|
Madrigal Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$502
|
$10.6B |
11.2x |
-36.1x |
|
Organon
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$9
|
$10.4B |
1.7x |
5.4x |
|
BioMarin Pharmaceutical
|
United States of America |
Drug Development & Therapeutics,
Regenerative Medicine
|
$55
|
$9.6B |
3.0x |
13.0x |
|
Halozyme Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$71
|
$9.2B |
6.9x |
10.5x |
|
Avidity Biosciences
|
United States of America |
Drug Development & Therapeutics
|
$73
|
$9.1B |
467.9x |
-13.5x |
|
Axsome Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$177
|
$8.8B |
14.0x |
-53.9x |
|
Praxis Precision Medicines
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$317
|
$8.5B |
28562.2x |
-28.7x |
|
Arrowhead Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$64
|
$8.3B |
11.5x |
208.2x |
|
Cytokinetics
|
United States of America |
Drug Development & Therapeutics
|
$63
|
$7.9B |
97.9x |
-13.0x |
|
Krystal Biotech
|
United States of America |
Drug Development & Therapeutics,
Regenerative Medicine
|
$285
|
$7.5B |
19.5x |
44.9x |
|
Nuvalent
|
United States of America |
Drug Development & Therapeutics
|
$104
|
$7.2B |
N/A |
-17.4x |
|
Amneal Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$13
|
$6.7B |
2.2x |
9.8x |
|
Rhythm Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$102
|
$6.5B |
34.7x |
-34.0x |
|
Cogent Biosciences
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$39
|
$5.8B |
N/A |
-21.4x |
|
ImmunityBio
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$6
|
$5.7B |
51.6x |
N/A |
|
Belite Bio
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$155
|
$5.5B |
N/A |
N/A |
|
Structure Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$89
|
$5.5B |
N/A |
-19.9x |
|
Perrigo
|
United States of America |
Health & Beauty,
Drug Development & Therapeutics
|
$15
|
$5.3B |
1.2x |
7.2x |
|
Kymera Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$70
|
$5.1B |
96.4x |
-16.3x |
|
Apogee Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$81
|
$5.0B |
N/A |
-17.7x |
|
TG Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$31
|
$5.0B |
8.2x |
35.9x |
|
Celcuity
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$107
|
$4.8B |
N/A |
-29.0x |
|
Crinetics Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$56
|
$4.7B |
957.4x |
-9.8x |
|
Mirum Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$91
|
$4.6B |
9.2x |
-295.0x |
|
Amicus Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Regenerative Medicine
|
$14
|
$4.6B |
7.3x |
43.4x |
|
Immunovant
|
United States of America |
Drug Development & Therapeutics
|
$26
|
$4.6B |
N/A |
-9.0x |
|
Protagonist Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$82
|
$4.6B |
70.7x |
-31.1x |
|
PTC Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$72
|
$4.5B |
2.5x |
4.8x |
|
Lantheus Holdings
|
United States of America |
Medical Imaging & Diagnostics,
Drug Development & Therapeutics
|
$64
|
$4.5B |
3.0x |
8.3x |
|
Scholar Rock
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$45
|
$4.3B |
N/A |
-10.9x |
|
Alkermes
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$32
|
$4.2B |
2.9x |
11.0x |
|
Prestige Consumer Healthcare
|
United States of America |
Health & Beauty,
Drug Development & Therapeutics
|
$65
|
$4.1B |
3.6x |
11.0x |
|
CG Oncology
|
United States of America |
Drug Development & Therapeutics
|
$55
|
$3.8B |
1418.3x |
-19.7x |
|
Terns Pharma
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$37
|
$3.7B |
N/A |
-32.8x |
|
ACADIA Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$26
|
$3.6B |
3.3x |
31.0x |
|
Arcellx
|
United States of America |
Drug Development & Therapeutics
|
$69
|
$3.6B |
109.9x |
-14.3x |
|
Ligand Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$193
|
$3.6B |
13.5x |
33.5x |
|
Legend Biotech
|
United States of America |
Drug Development & Therapeutics
|
$22
|
$3.5B |
3.4x |
-27.4x |
|
CRISPR Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Regenerative Medicine
|
$54
|
$3.4B |
421.7x |
-6.1x |
|
Liquidia
|
United States of America |
Drug Development & Therapeutics,
Drug Delivery Systems
|
$38
|
$3.3B |
22.7x |
-62.4x |
|
Corcept Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$35
|
$3.2B |
4.0x |
22.4x |
|
Viking Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$34
|
$3.1B |
N/A |
-9.3x |
|
Arcutis Biotherapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$26
|
$3.1B |
8.6x |
-1609.5x |
|
Viridian Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$33
|
$2.9B |
33.5x |
-10.2x |
|
NewAmsterdam Pharma Co
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$32
|
$2.9B |
105.7x |
-13.7x |
|
Vera Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$47
|
$2.9B |
N/A |
-9.7x |
|
Alvotech
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$5
|
$2.8B |
4.7x |
21.1x |
|
Tarsus Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$71
|
$2.7B |
6.1x |
-42.5x |
|
Kiniksa Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$39
|
$2.6B |
3.9x |
24.7x |
|
Xenon Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$40
|
$2.6B |
348.8x |
-7.3x |
|
Alumis
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$24
|
$2.6B |
106.1x |
-10.8x |
|
Supernus Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$50
|
$2.6B |
3.7x |
20.6x |
|
Sarepta Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$21
|
$2.6B |
1.2x |
-7.3x |
|
Travere Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$28
|
$2.6B |
5.2x |
290.6x |
|
Adaptive Biotech
|
United States of America |
Pharma Diagnostics & Analytics,
Drug Development & Therapeutics
|
$18
|
$2.5B |
9.6x |
-1241.1x |
|
Apellis Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$20
|
$2.5B |
2.5x |
32.3x |
|
Ascentage Pharma
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$27
|
$2.5B |
33.7x |
-18.8x |
|
Erasca
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$10
|
$2.5B |
N/A |
-17.3x |
|
Spyre Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$33
|
$2.4B |
N/A |
-11.4x |
|
IDEAYA Biosciences
|
United States of America |
Drug Development & Therapeutics
|
$36
|
$2.4B |
11.0x |
-15.3x |
|
Phibro Animal Health
|
United States of America |
Drug Development & Therapeutics
|
$41
|
$2.4B |
1.7x |
11.3x |
|
WAVE Life Sciences
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$14
|
$2.4B |
56.1x |
-11.7x |
|
Edgewise Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$27
|
$2.3B |
N/A |
-12.7x |
|
ANI Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$85
|
$2.3B |
2.6x |
10.0x |
|
Beam Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Regenerative Medicine
|
$31
|
$2.2B |
60.0x |
-4.7x |
|
Immunome
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$22
|
$2.2B |
283.3x |
-10.5x |
|
Ocular Therapeutix
|
United States of America |
Drug Development & Therapeutics,
Drug Delivery Systems
|
$11
|
$2.1B |
38.9x |
-8.0x |
|
Catalyst Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$23
|
$2.1B |
3.6x |
7.7x |
|
Disc Medicine
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$71
|
$2.1B |
N/A |
-8.8x |
|
Dyne Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$17
|
$2.1B |
N/A |
-4.7x |
|
Avadel Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$21
|
$2.0B |
7.3x |
58.5x |